Real-time enrollment status for this neuroblastoma clinical trial
Current Status
Recruiting
Checked: July 20, 2026 at 1:18 AM UTC
| NCT Number | NCT06057948 |
| Recruiting Status | Recruiting |
| Condition | Neuroblastoma |
| Phase | PHASE2 |
| Target Enrollment | 94 participants |
| Active Locations | 7 sites in the US |
| Sponsor | Memorial Sloan Kettering Cancer Center |
| Last Updated on CT.gov | June 5, 2026 (Jun 5, 2026) |
As of July 20, 2026: Clinical trial NCT06057948 is currently recruiting participants. This phase2 study for neuroblastoma is actively seeking new participants at 7 locations across the United States. The study is sponsored by Memorial Sloan Kettering Cancer Center. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06057948 is actively recruiting participants as of July 20, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 7 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06057948 was last updated Jun 5, 2026 (June 5, 2026). HelloStudys verifies this status automatically.